Extending these observations, FASN expression negatively correlated with three derived measures of T-cell receptor (TCR) repertoire enrichment in both breast cancer and pan-cancer datasets (PCCs ranging from −0.014 to −0.06; FDR-adjusted p-values < 10−4). Here, FASN is linked to cancer.